MCHP MICROCHIP TECHNOLOGY INC Insider Trading

MCHP: SVP Operations Bunker sold 10,571 shares at $96.88; holds 14,587 post-sale amid -42.4% annual revenue decline

Bunker Mathew B, Senior VP Operations, sold 10,571 shares (42.0% of his pre-transaction holdings) at $96.88 on 2026-05-13 for $1,024,155.48. The sale occurs against a backdrop of severe business deterioration: annual revenue declined 42.4% year-over-year, and Microchip Technology was unprofitable over its most recent full fiscal year. The current stock price of $93.85 is 11.4% below the 52-week high of $105.91, suggesting the company has already faced significant valuation pressure. While the 30-day change of +26.0% indicates recent recovery momentum, the fundamental revenue contraction and full-year loss signal material operational challenges that warrant investor attention to upcoming guidance and turnaround progress.

COO Richard Simoncic sells 10,000 MCHP shares at $97.55 amid -42.4% annual revenue decline and current losses.

Simoncic sold 10,000 shares at $97.55, reducing his holdings from 146,127 to 136,127 shares. The sale occurs while Microchip faces material operational headwinds: annual revenue declined 42.4% and the company is currently unprofitable with net income of $62.7M against quarterly revenue of $1.2B. The stock has risen 26.0% over the past 30 days and 19.5% over 90 days, trading 11.4% below its 52-week high of $105.91. The transaction warrants investor attention given the backdrop of significant revenue contraction, but the modest share reduction and executive's substantial retained position (136.1K shares) provide limited directional signals.

MCHP CEO sells ~110K shares worth ~$10.3M as stock hits 52-week highs

Steve Sanghi, MCHP's CEO and board chair, executed two sales totaling approximately $10.3 million in shares across consecutive trading days while the stock was trading at or near its highest level in a year. The timing is notable: the stock has surged significantly over the past month and currently sits at all-time highs, a classic window when insiders often choose to rebalance holdings. However, the sales represent a modest portion of Sanghi's total position—less than 1.2% combined—suggesting this is portfolio rebalancing rather than a sign of loss of confidence in the company's trajectory. The company's fundamentals show net losses and mixed profitability signals, which provides limited clarity on whether Sanghi is exiting due to valuation concerns or simply harvesting gains from a strong run. Without additional context about Sanghi's historical trading patterns, this filing registers as a routine executive action at elevated prices rather than a red flag.

CEO Steve Sanghi sold 416,581 shares of MCHP at $88.53 for $36,881,124.01 under pre-arranged 10b5-1 plan

Steve Sanghi, President, CEO and Chair, sold 416,581 shares at $88.53 on 2026-04-23 pursuant to a pre-arranged 10b5-1 trading plan adopted on 2025-06-06, reducing his holdings from 9,912,386 shares to 9,495,805 shares. The sale generated $36,881,124.01 in proceeds and represents a -4.2% reduction in his post-transaction holdings. Because this transaction is part of a scheduled 10b5-1 plan rather than discretionary trading, it reflects a pre-committed disposition rather than a real-time market decision. The CEO retains significant holdings of 9,495,805 shares, indicating continued material ownership stake in the company.

CEO Sanghi sells 94.9K shares of MCHP at $82.46; retains 9.83M shares as company faces -42.4% annual revenue decline

Sanghi Steve, President, CEO and Chair of Board, sold 94,869 shares at $82.46 on 2026-02-12 for total value of $7,823,191.83, reducing holdings from 9,922,319 to 9,827,450 shares (a -1.0% reduction). The sale occurred near the 52-week high of $80.75, but stock has since declined to $78.94 current price. At MCHP specifically, his prior two measurable sales (both on 2024-03-07) posted 90-day returns of +1.6% and +0.3%, neither well-timed by the standard that sells are well-timed when the stock falls after. More pressingly, the company is navigating severe headwinds: annual revenue contracted -42.4% versus prior fiscal year, the company was unprofitable over its most recent full fiscal year, and latest quarterly revenue stands at $1,186,000,000 with net income of only $62,700,000. Against this deteriorating operating backdrop, the CEO's sale—while modest as a percentage of holdings—occurs in a context of macro weakness that warrants monitoring.

MCHP CEO Sanghi sold 98,814 shares at $80.55 on 2026-01-28 via pre-arranged 10b5-1 plan; retains 9,922,319 shares

CEO Steve Sanghi executed a sale of 98,814 shares for $7,959,813.55 on 2026-01-28 under a 10b5-1 trading plan adopted on 2025-06-06, meaning this transaction was scheduled in advance rather than discretionary. His post-transaction holding of 9,922,319 shares represents a -1.0% reduction from his pre-transaction position of 10,021,133 shares. As a pre-arranged plan execution, this sale reflects predetermined scheduling rather than a market-timing decision or response to current business conditions.

CEO Sanghi sells 18,509 shares of MCHP at $79.20 under 10b5-1 plan; retains 10,021,133 shares post-transaction

Sanghi Steve, President, CEO and Chair, sold 18,509 shares at $79.20 on 2026-01-22 for $1,465,883.19, reducing his stake from 10,039,642 to 10,021,133 shares. This sale is part of a pre-arranged 10b5-1 trading plan adopted on 2025-06-06, meaning it was scheduled and not a discretionary market decision. The sale represents a -0.2% reduction in his holdings, a modest dislocation. As a scheduled transaction under a 10b5-1 plan, this activity reflects a predetermined program rather than a response to current market conditions or company developments.

MCHP CFO Bjornholt sold 7,356 shares for $505,495.68 via scheduled 10b5-1 plan (adopted 2025-05-23).

Bjornholt James Eric, Senior VP and CFO, executed 2 separate sales totaling 7,356 shares for $505,495.68 on 2025-08-25 under a pre-arranged 10b5-1 trading plan adopted on 2025-05-23. The plan-based nature of this transaction means it was scheduled and non-discretionary, removing any implication of market-timing or conviction-based decision-making. Holdings declined from 37,366 shares to 30,010 shares, a reduction of 19.7% relative to pre-transaction holdings. The sale represents routine portfolio activity by a CFO under an established, prescheduled framework rather than a sudden or discretionary action.